Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display-Reference-Cited by-同舟云学术

Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display

Published:2023 Issue:2 Volume:11 Page:596-610
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Butkovich Nina¹,Tucker Jo Anne²,Ramirez Aaron¹^ORCID,Li Enya¹,Meli Vijaykumar S.³^ORCID,Nelson Edward L.²⁴⁵^ORCID,Wang Szu-Wen¹⁴⁵³^ORCID

Affiliation:

1. Department of Chemical and Biomolecular Engineering, University of California, Irvine, CA 92697, USA

2. Department of Medicine, University of California, Irvine, CA 92697, USA

3. Department of Biomedical Engineering, University of California, Irvine, CA 92697, USA

4. Chao Family Comprehensive Cancer Center, University of California, Irvine, CA 92697, USA

5. Institute for Immunology, University of California, Irvine, CA 92697, USA

Abstract

Plasmacytoid dendritic cells (pDCs) can assist myeloid dendritic cells (mDCs) to increase antigen display in response to nanoparticle-based vaccines.

Funder

National Institute of Biomedical Imaging and Bioengineering

National Cancer Institute

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/BM/D2BM01132H

Reference89 articles.

1. L.Richardson , N.Dowling and J.Henley , An Update on Cancer Deaths in the United States, https://www.cdc.gov/cancer/dcpc/research/update-on-cancer-deaths/index.htm

2. Cancer and Radiation Therapy: Current Advances and Future Directions

3. Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe

4. Mortality due to cancer treatment delay: systematic review and meta-analysis

5. The Intriguing History of Cancer Immunotherapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-pronged anti-cancer nanovaccines enpowered by exogenous/endogenous tumor-associated antigens;Journal of Controlled Release;2024-09

2. Endogenous capsid-forming protein ARC for self-assembling nanoparticle vaccines;Journal of Nanobiotechnology;2024-08-27

3. Immune signature and phagocytosis of circulating DC subsets in healthy adults during aging;International Immunopharmacology;2024-03

4. Preparation of viromimetic rod-like nanoparticle vaccines (RLNVax) and study of their humoral immune activation efficacy;Biomaterials Science;2024

5. Emerging nanoparticle platforms for CpG oligonucleotide delivery;Biomaterials Science;2024